Target intelligence / Profile preview

Alpha-smooth muscle actin (α-SMA)

Target
α-SMA
Molecular classification
Structural protein, Actin isoform, Cytoskeletal protein
01

Overview

Alpha-smooth muscle actin (α-SMA) is a specialized actin isoform predominantly expressed in vascular and visceral smooth muscle cells, encoded by the ACTA2 gene. It is a globular structural protein that polymerizes to form filaments (microfilaments), forming a key component of the cytoskeleton and contractile apparatus in muscle cells. In non-muscle cells, notably myofibroblasts, α-SMA expression correlates with increased contractile activity important for wound healing, matrix remodeling, and fibrogenesis. α-SMA is a hallmark marker of myofibroblast activation and is used extensively in research and pathology as a biomarker for fibrosis and tissue repair processes. Mutations in ACTA2 underpin a range of vascular and fibrotic diseases. Although it plays crucial roles in cellular contractility and mechanotransduction, it is not a classical drug target such as a receptor, transporter, or enzyme, but rather serves as a structural marker and effector in disease-related cellular phenotypes.

Other names
ACTA2actin alpha 2alpha-actin-2aortic smooth muscle actinSMactinalpha-SM-actinASMA
02

Biological functions

Muscle contractionCell-generated mechanical tensionMatrix remodelingMechanotransductionFibrogenesisCell migration modulation
03

Disease associations

Fibrosis (e.g., liver, lung, heart)Vascular diseases (e.g., thoracic aortic disease, coronary artery disease, stroke, Moyamoya disease, multisystemic smooth muscle dysfunction)Cancer (stromal reaction, wound repair, fibrotic tumor microenvironment)
04

Safety considerations

Targeting alpha-smooth muscle actin may disrupt essential contractile functions of vascular and visceral smooth muscleChallenges in targeting due to high homology with other actin isoforms
05

Biomarkers

Marker for myofibroblast formation and activationIndicator for fibrotic activity

Beyond the preview

Go deeper on Alpha-smooth muscle actin (α-SMA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-smooth muscle actin (α-SMA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call